TagsHepatology 
Switching for a Better Renal Outcome in the Management of Chronic Hepatitis B

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, with an estimated global prevalence of 5–7% in school-aged children. It is characterised by hyperactivity and impulsivity with ...

Aug 11, 2023
POEMS Syndrome – A Rare and Challenging Disorder

The POEMS syndrome is a rare plasma cell disorder involving pathological changes of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes. The diagnostic and therapeutic management of the disease is clinically challenging. Given ...

Jun 13, 2023
The 9th Annual Scientific Meeting of the Hong Kong Society of Hepatobiliary and Pancreatic Surgery

The 9 th Annual Scientific Meeting of the Hong Kong Society of Hepatobiliary and Pancreatic Surgery Liver cancer is one of the leading causes of cancer-related death globally. The prognosis of liver cancers is usually poor, and predicting life expec...

Jun 21, 2021
HCV Micro-elimination in Hong Kong, Insights from AASLD the Liver Meeting

“The current progress of HCV elimination in Hong Kong is a bit left behind, yet latest strategies and policy have loosen access criteria for Direct-Acting Antiviral (DAA) therapies, making it possible for Hong Kong to catch up with other count...

Mar 16, 2021
Treatment on Antibiotic Resistance in Helicobacter Pylori 

Treatment on Antibiotic Resistance in Helicobacter Pylori Helicobacter pylori (H. pylori) is a bacterium that infects more than half of the worldwide population. H. pylori infection is the main cause of chronic gastritis and the etiological agent fo...

Mar 16, 2021
HCV Micro-elimination in Hong Kong, Insights from AASLD the Liver Meeting

"The current progress of HCV elimination in Hong Kong is a bit left behind, yet latest strategies and policy have loosen access criteria for Direct-Acting Antiviral (DAA) therapies, making it possible for Hong Kong to catch up with other countr...

Dec 28, 2020
The Current Step Forward towards Hepatitis C Virus Elimination

Current Efforts on HCV Elimination in Hong Kong “There is still a long way to go if Hong Kong were to achieve the WHO goal by 2030,” commented Dr. Mak. Indeed, a retrospective study by Hui et al (2018) involving 11,309 anti-HCV positive ...

Jun 16, 2020
Moving Forward and Beyond - What’s Next for HCV in Hong Kong

Current Handling of HCV Treatment With the current approach of hepatitis C virus (HCV) treatment, Hong Kong has aligned itself with the World Health Organization (WHO) strategy to eliminate viral hepatitis as a major public health threat by 2030 1 ....

Jun 15, 2020
A Change for Better Management of HBV Infection – When and How?

Pharmacological Advantages of TAF over TDF Both TDF and TAF are recommended as the first-line therapy for CHB management 5 . However, TAF is more stable than TDF in plasma and delivers the active metabolite to hepatocytes more efficiently, allowing ...

Mar 16, 2020
The Essence of Hepatitis C Virus Elimination

Broken Linkage to Care According to the World Health Organization (WHO), globally there were less than 5% of hepatitis C virus (HCV)-infected patients who received an HCV diagnosis whereas less than 1% received HCV treatment 1 . Recently, Hui et al ...

Dec 16, 2019